Fusion Protein Inhibitor for RSV Shows Efficacy in Phase 2 Trial
The oral respiratory syncytial virus (RSV) fusion protein inhibitor AK0529 was found to be well tolerated and reduced viral load in infants.
Stay updated with breaking news from Phase 2. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The oral respiratory syncytial virus (RSV) fusion protein inhibitor AK0529 was found to be well tolerated and reduced viral load in infants.
Shares of MyMD Pharmaceuticals, Inc. (MYMD) are up 9% on Monday after the company reported that it achieved its primary and secondary endpoints from its randomized Phase 2 study of oral TNF-a inhibitor, MYMD-1 in patients with chronic inflammation associated with sarcopenia, or age-related frailty.
Phase 2 will run from the west midlands, linking birmingham with manchester. phase 2 is split into two parts. phase 2a will run from birmingham to crewe, whilst phase 2b will extend the route from crewe to manchester and from the west midlands to east midlands parkway. but from the start, the project has been beset by delays and spiralling costs. the london to birmingham line was supposed to open in 2026, but now might not be operational until 2033, causing frustration among some advocates who want to reap the economic benefits they believe will come with shorter journey times. but yesterday, ...
The three-part competition aims to inspire improvements in worker safety.
This segment of her interview with HCPLive featured a discussion with Ferris on the FRONTIER 1 phase 2b trial results and their implications for psoriasis patients.